Home > Insider Trading > Filing (0001628280-24-019355)

Filing Details

Accession Number:: 0001628280-24-019355
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2024-04-30 16:18:31
Reporting Period:: 2024-04-18

Accepted Time:: 2024-04-30 16:18:31
Original Submission Date:: 2024-04-22
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1289850	Neurometrix Inc.	NURO	Surgical & Medical Instruments & Apparatus (3841)	043308180

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1612424	Joshua Horowitz	C/O Neurometrix, Inc. 4B Gill Street Woburn MA 01801		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2024-04-18	16,438	$0.00	24,438	No	4	A	Direct
Common Stock	Disposition	2024-04-22	1,000	$4.58	23,438	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	A	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	60,500	Indirect	See footnote

Footnotes

Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs were issued to the Reporting Person as the initial grant to non-employee directors pursuant to the Issuer's policy for compensating non-employee directors for services to be rendered to the Issuer as a member of its Board of Directors. The RSUs vest in four equal quarterly installments beginning June 30, 2024, with full vesting to occur on the earlier of the date of the 2025 annual meeting of stockholders or a change in control of the Issuer, subject to the Reporting Person's continued service on the Board of Directors on such date.
This amendment is being filed solely to correct an error on the original Form 4, filed on April 22, 2024 by the Reporting Person (the "Original Form 4"), pursuant to which the Original Form 4 did not report an inadvertent sale that occurred on April 22, 2024 of 1,000 shares of the Issuer's common stock (at $4.58 per share). The number of shares presented on this amendment to the Original Form 4 represents the current number of shares beneficially owned by the Reporting Person.
Held by Palm Global Small Cap Master Fund LP Palm Management (US) LLC, as the investment manager of Palm Global Small Cap Master Fund LP ("Palm Global"), may be deemed to be a beneficial owner of the shares of Common Stock disclosed as directly owned by Palm Global. Due to his positions with Palm Global and Palm Management (US) LLC, the Reporting Person may be deemed to be a beneficial owner of the shares of Common Stock disclosed as directly owned by Palm Global Palm Management (US) LLC and the Reporting Person expressly disclaim such beneficial ownership except to the extent of their pecuniary interest therein.